RecruitingObesity and Obesity-related Medical Conditions
Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
Eligible age
18–65 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; whether this causes more complications or side effects compared to surgery alone.
Sponsor: Nicholas Skertich
You may qualify if…
- ✓ Adult 18 to 65 years of age
- ✓ Body Mass Index \>35 with comorbidity of Type 2 Diabetes and/or Hypertension and/or Hyperlipidemia and/or Obstructive Sleep Apnea OR Body Mass Index \>40 with or without comorbidity
- ✓ Undergoing primary sleeve gastrectomy
You may not qualify if…
- ✕ Prior metabolic and bariatric surgery
- ✕ Prior use of GLP-1 agonist
- ✕ Prior history of pancreatitis
- ✕ Personal/family history of medullary thyroid cancer or MEN type 2
- ✕ Secondary cause of obesity
- ✕ Any eating disorder
- ✕ Pregnancy/lactation
- ✕ History of acute coronary syndrome or myocardial infarction
Where it's recruiting
Illinois
Chicago
Source: ClinicalTrials.gov · NCT06734273 · last updated 2026-05-08